Kevin K. Roggin to Aged
This is a "connection" page, showing publications Kevin K. Roggin has written about Aged.
Connection Strength
0.574
-
Can Comprehensive Imaging Analysis with Analytic Morphomics and Geriatric Assessment Predict Serious Complications in Patients Undergoing Pancreatic Surgery? J Gastrointest Surg. 2017 06; 21(6):1009-1016.
Score: 0.045
-
Prospective clinical trial of diagnostic peritoneal lavage to detect positive peritoneal cytology in patients with gastric cancer. J Surg Oncol. 2013 Jun; 107(8):794-8.
Score: 0.034
-
A review of resistance patterns and phenotypic changes in gastrointestinal stromal tumors following imatinib mesylate therapy. J Gastrointest Surg. 2007 Jun; 11(6):758-66.
Score: 0.023
-
Limitations of ampullectomy in the treatment of nonfamilial ampullary neoplasms. Ann Surg Oncol. 2005 Dec; 12(12):971-80.
Score: 0.020
-
Resection Status Does Not Impact Recurrence in Well-Differentiated Liposarcoma of the Extremity. Am Surg. 2021 Nov; 87(11):1752-1759.
Score: 0.016
-
A multi-institutional validation study of prognostic nomograms for retroperitoneal sarcoma. J Surg Oncol. 2021 Oct; 124(5):829-837.
Score: 0.015
-
Personalized Antibodies for Gastroesophageal Adenocarcinoma (PANGEA): A Phase II Study Evaluating an Individualized Treatment Strategy for Metastatic Disease. Cancer Discov. 2021 02; 11(2):308-325.
Score: 0.015
-
Impact of resection margin on outcomes in high-grade soft tissue sarcomas of the extremity-A USSC analysis. J Surg Oncol. 2021 Feb; 123(2):479-488.
Score: 0.014
-
High neutrophil-lymphocyte ratio is not independently associated with worse survival or recurrence in patients with extremity soft tissue sarcoma. Surgery. 2020 10; 168(4):760-767.
Score: 0.014
-
Analysis of textbook outcomes among patients undergoing resection of retroperitoneal sarcoma: A multi-institutional analysis of the US Sarcoma Collaborative. J Surg Oncol. 2020 Nov; 122(6):1189-1198.
Score: 0.014
-
Risk factors for complications in patients undergoing pancreaticoduodenectomy: A NSQIP analysis with propensity score matching. J Surg Oncol. 2020 Aug; 122(2):183-194.
Score: 0.014
-
Neoadjuvant radiation improves margin-negative resection rates in extremity sarcoma but not survival. J Surg Oncol. 2020 Jun; 121(8):1249-1258.
Score: 0.014
-
Outcomes of palliative-intent surgery in retroperitoneal sarcoma-Results from the US Sarcoma Collaborative. J Surg Oncol. 2020 Jun; 121(7):1140-1147.
Score: 0.014
-
PLR and NLR Are Poor Predictors of Survival Outcomes in Sarcomas: A New Perspective From the USSC. J Surg Res. 2020 07; 251:228-238.
Score: 0.014
-
Evaluation of the Association of Perioperative UGT1A1 Genotype-Dosed gFOLFIRINOX With Margin-Negative Resection Rates and Pathologic Response Grades Among Patients With Locally Advanced Gastroesophageal Adenocarcinoma: A Phase 2 Clinical Trial. JAMA Netw Open. 2020 02 05; 3(2):e1921290.
Score: 0.014
-
Trends in the Use of Adjuvant Chemotherapy for High-Grade Truncal and Extremity Soft Tissue Sarcomas. J Surg Res. 2020 01; 245:577-586.
Score: 0.013
-
Role of radiation therapy for retroperitoneal sarcomas: An eight-institution study from the US Sarcoma Collaborative. J Surg Oncol. 2019 Dec; 120(7):1227-1234.
Score: 0.013
-
Lung Surveillance Strategy for High-Grade Soft Tissue Sarcomas: Chest X-Ray or CT Scan? J Am Coll Surg. 2019 11; 229(5):449-457.
Score: 0.013
-
The role of radiation therapy and margin width in localized soft-tissue sarcoma: Analysis from the US Sarcoma Collaborative. J Surg Oncol. 2019 Sep; 120(3):325-331.
Score: 0.013
-
Validating the Electronic Cardiac Arrest Risk Triage (eCART) Score for Risk Stratification of Surgical Inpatients in the Postoperative Setting: Retrospective Cohort Study. Ann Surg. 2019 06; 269(6):1059-1063.
Score: 0.013
-
Outcomes of Elderly Patients Undergoing Curative Resection for Retroperitoneal Sarcomas: Analysis From the US Sarcoma Collaborative. J Surg Res. 2019 01; 233:154-162.
Score: 0.012
-
Perioperative chemotherapy is not associated with improved survival in high-grade truncal sarcoma. J Surg Res. 2018 11; 231:248-256.
Score: 0.012
-
Studying a Rare Disease Using Multi-Institutional Research Collaborations vs Big Data: Where Lies the Truth? J Am Coll Surg. 2018 09; 227(3):357-366.e3.
Score: 0.012
-
The impact of changes in radiographic sarcopenia on overall survival in older adults undergoing different treatment pathways for pancreatic cancer. J Geriatr Oncol. 2018 07; 9(4):367-372.
Score: 0.012
-
Minimally invasive pancreatoduodenectomy: is the incidence of clinically relevant postoperative pancreatic fistula comparable to that after open pancreatoduodenectomy? Surgery. 2018 03; 163(3):587-593.
Score: 0.012
-
Liver transplant offers a survival benefit over margin negative resection in patients with small unifocal hepatocellular carcinoma and preserved liver function. Surgery. 2018 03; 163(3):582-586.
Score: 0.012
-
Does adjuvant radiation provide any survival benefit after an R1 resections for pancreatic cancer? Surgery. 2018 05; 163(5):1047-1052.
Score: 0.012
-
The extent of vascular resection is associated with perioperative outcome in patients undergoing pancreaticoduodenectomy. HPB (Oxford). 2018 02; 20(2):140-146.
Score: 0.012
-
Primary systemic therapy in resectable pancreatic ductal adenocarcinoma using mFOLFIRINOX: A pilot study. J Surg Oncol. 2018 Mar; 117(3):354-362.
Score: 0.012
-
Orthotopic liver transplantation provides a survival advantage compared with resection in patients with hepatocellular carcinoma and preserved liver function. Surgery. 2017 11; 162(5):1032-1039.
Score: 0.012
-
Laparoscopic pancreaticoduodenectomy for adenocarcinoma provides short-term oncologic outcomes and long-term overall survival rates similar to those for open pancreaticoduodenectomy. Am J Surg. 2017 Mar; 213(3):512-515.
Score: 0.011
-
Perioperative chemotherapy is associated with a survival advantage in early stage adenocarcinoma of the pancreatic head. Surgery. 2016 09; 160(3):714-24.
Score: 0.011
-
Radiographic Sarcopenia and Self-reported Exhaustion Independently Predict NSQIP Serious Complications After Pancreaticoduodenectomy in Older Adults. Ann Surg Oncol. 2015 Nov; 22(12):3897-904.
Score: 0.010
-
Early National Experience with Laparoscopic Pancreaticoduodenectomy for Ductal Adenocarcinoma: A Comparison of Laparoscopic Pancreaticoduodenectomy and Open Pancreaticoduodenectomy from the National Cancer Data Base. J Am Coll Surg. 2015 Jul; 221(1):175-84.
Score: 0.010
-
The laparoscopic approach to distal pancreatectomy for ductal adenocarcinoma results in shorter lengths of stay without compromising oncologic outcomes. Am J Surg. 2015 Mar; 209(3):557-63.
Score: 0.010
-
Comparison of tumor markers for predicting outcomes after resection of nonfunctioning pancreatic neuroendocrine tumors. Surgery. 2014 Dec; 156(6):1504-10; discussion 1510-1.
Score: 0.010
-
Is multimodality therapy necessary for the management of pure myxoid liposarcomas? A multi-institutional series of pure myxoid liposarcomas of the extremities and torso. J Surg Oncol. 2015 Feb; 111(2):146-51.
Score: 0.009
-
Geriatric assessment improves prediction of surgical outcomes in older adults undergoing pancreaticoduodenectomy: a prospective cohort study. Ann Surg. 2014 May; 259(5):960-5.
Score: 0.009
-
Pathologic grade and tumor size are associated with recurrence-free survival in patients with duodenal neuroendocrine tumors. J Gastrointest Surg. 2014 Mar; 18(3):457-62; discussion 462-3.
Score: 0.009
-
Predicting aggressive behavior in nonfunctioning pancreatic neuroendocrine tumors. Surgery. 2013 Oct; 154(4):785-91; discussion 791-3.
Score: 0.009
-
Differential cell cycle-regulatory protein expression in biliary tract adenocarcinoma: correlation with anatomic site, pathologic variables, and clinical outcome. J Clin Oncol. 2006 Mar 01; 24(7):1152-60.
Score: 0.005
-
Papillary phenotype confers improved survival after resection of hilar cholangiocarcinoma. Ann Surg. 2005 May; 241(5):703-12; discussion 712-4.
Score: 0.005